TherapySelect Dr. Frank Kischkel is a biotech and medtech company. It focusses on development, clinical validation, marketing and sales of diagnostic tests for cancer patients. The company's aim is to increase patient's survival and quality of life as well as to reduce costs in health care system. TherapySelect has three main areas of activity: 1. Development and sales of its own or licensed products 2. Distribution of other diagnostic tests 3. Offering its diagnostic platform(s) to pharma companies for product development
View Top Employees from TherapySelect Dr. Frank Kischkel| Website | http://www.therapyselect.de/de |
| Revenue | $405000 |
| Employees | 2 (2 on RocketReach) |
| Address | Carl-Bosch-Straße 4, Heidelberg, Baden-Württemberg 69115, DE |
| Phone | +49 6221 8936152 |
| Fax | +49 6221 8936153 |
| Technologies |
JavaScript,
HTML,
PHP
+12 more
(view full list)
|
| Industry | Medical Practices, Hospitals & Clinics, Healthcare |
| Competitors | BIOTRON LIMITED, CNBX Pharmaceuticals, GeneCentric Therapeutics, Inc., Matritech, Inc., Microgen Bioproducts Ltd. |
| SIC | SIC Code 80 Companies, SIC Code 806 Companies |
| NAICS | NAICS Code 62 Companies, NAICS Code 62231 Companies, NAICS Code 6223 Companies, NAICS Code 622310 Companies, NAICS Code 622 Companies |
Looking for a particular TherapySelect Dr. Frank Kischkel employee's phone or email?
TherapySelect Dr. Frank Kischkel Questions
The TherapySelect Dr. Frank Kischkel annual revenue was $405000 in 2024.
Frank Kischkel is the Owner of TherapySelect Dr. Frank Kischkel.
2 people are employed at TherapySelect Dr. Frank Kischkel.
TherapySelect Dr. Frank Kischkel is based in Heidelberg, Baden-Württemberg.
The NAICS codes for TherapySelect Dr. Frank Kischkel are [62, 62231, 6223, 622310, 622].
The SIC codes for TherapySelect Dr. Frank Kischkel are [80, 806].
Top TherapySelect Dr. Frank Kischkel Employees
Related Companies
